Max Robotics — Global Service Robot Directory + US Certification

About

Michele Molinari is a leading figure in the advancement of minimally invasive hepatobiliary and transplant surgery, with a particular focus on robotic-assisted techniques. His research has been instrumental in demonstrating the long-term oncologic safety and efficacy of robotic liver resections for both primary hepatobiliary malignancies and metastatic colorectal cancer. In a landmark multicenter study (94 citations), he and his colleagues provided critical evidence supporting the oncologic adequacy of robotic approaches for primary liver cancers. Further solidifying this position, his propensity score-matched analysis (86 citations) compared robotic versus laparoscopic liver resection for colorectal metastases, offering robust data on long-term outcomes that have helped guide surgical decision-making. Beyond the liver, Molinari has explored the application of robotics in renal transplantation, particularly for obese patients, where he has developed cost-benefit models to assess the value of these advanced techniques. Through his work, Molinari has not only validated the role of robotics in complex oncologic surgery but has also provided the rigorous comparative data necessary for its broader adoption, making him a key contributor to the evolution of modern surgical practice.